Zoetis Inc. (NYSE:ZTS) Q1 2026 Earnings Call Transcript
Operator: Welcome to the First Quarter 2026 Financial Results Conference Call and Webcast for Zoetis. Hosting the call today is Steve Frank, Vice President of Investor Relations for Zoetis.
Zoetis Inc. (ZTS)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Diamond Hill Capital Ric Dillon | 2,927,462 | $346,055,283 | -8% | 2.16% |
| 2. | Leucadia National Ian Cumming And Joseph Steinberg | 19,710 | $2,329,919 | +3% | 0.02% |
| 3. | Prescott Group Capital Management Phil Frohlich | 19,500 | $2,305,095 | 0.23% | |
| 4. | Zevenbergen Capital Investments Nancy Zevenbergen | 12,420 | $1,468,168 | -15% | 0.04% |
| 5. | Fisher Asset Management Ken Fisher | 2,344 | $277,178 | -22% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $165.48 | 2,100 | $347,508.00 | 7,590 | 2021-02-19 | Filing | |
| $164.89 | 2,900 | $478,181.00 | 5,490 | 2021-02-19 | Filing | |
| $163.80 | 2,590 | $424,242.00 | 2,590 | 2021-02-19 | Filing | |
| $74.56 | 10 | $745.60 | 17 | 2018-01-11 | Filing | |
| $50.31 | 7 | $352.17 | 7 | 2016-10-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $127.55 | 10,800 | $1,377,531.36 | 101,337 | 2026-02-17 | Filing | |
| $126.46 | 9,200 | $1,163,432.92 | 112,137 | 2026-02-17 | Filing | |
| $170.00 | 652 | $110,840.00 | 15,129 | 2025-06-03 | Filing | |
| $170.00 | 326 | $55,420.00 | 15,781 | 2025-03-10 | Filing | |
| $166.14 | 1,210 | $201,029.40 | 11,245 | 2025-03-11 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 26,072,846 | $3,082,071,126 | 0.08% | |
| 2. | 23,967,400 | $2,833,186,354 | 0.15% | |
| 3. | 5,532,028 | $653,941,030 | 0.22% | |
| 4. | 3,899,720 | $460,985,944 | 0.08% | |
| 5. | 3,650,753 | $431,555,513 | 0.1% |
News See All
Zoetis Inc. (ZTS) Announces Expansion of Capabilities of Vetscan OptiCell
Zoetis Inc. (NYSE:ZTS) is one of the best drug stocks to buy according to analysts. On April 21, Zoetis Inc.
9 Best Drug Stocks to Buy According to Analysts
On April 27, Jurrien Timmer, director of global macro at Fidelity Investments, appeared on CNBC to talk about the market and oil prices, and how necessary it is for oil prices to retreat from their highs...
Is Zoetis Inc. (ZTS) A Good Stock To Buy Now?
Is ZTS a good stock to buy? We came across a bullish thesis on Zoetis Inc. on Quality At A Fair Price’s Substack. In this article, we will summarize the bulls’ thesis on ZTS.
Do You Believe in Zoetis’ (ZTS) Long-Term Growth Potential?
Mairs & Power, an investment advisor, released the fourth-quarter 2025 investor letter for the “Mairs & Power Growth Fund.” A copy of the letter is available for download here.
Bristol Gate Capital Partners Sold Zoetis (ZTS) Due to Deteriorating Dividend Growth
Bristol Gate Capital Partners, an investment management company, published its Q4 2025 investor letter for the “US Equity Strategy”. A copy of the letter can be downloaded here.
What Makes Zoetis (ZTS) an Investment Bet?
Diamond Hill Capital, an investment management company, released its “Mid Strategy” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Is Zoetis Inc. (ZTS) A Good Stock To Buy Now?
Is ZTS a good stock to buy now? We came across a bullish thesis on Zoetis Inc. on Rebound Capital’s Substack. In this article, we will summarize the bulls’ thesis on ZTS.
Jensen Quality Growth Equity Strategy Decided to Sell Its Stake in Zoetis (ZTS)
Jensen Investment Management, an asset management company based in the US, released its fourth-quarter investor letter for “Jensen Quality Growth Equity Strategy”.
Barclays Remains a Hold on Zoetis Inc. (ZTS)
Zoetis Inc. (NYSE:ZTS) is one of the best pet stocks to buy according to hedge funds. Barclays reaffirmed a Hold rating on Zoetis Inc. (NYSE:ZTS) on February 18, setting a price target of $136.00.
Hedge Fund Resource Center